lidocaine has been researched along with Colonic Diseases in 9 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intrathecal lidocaine in the dosage range tested during isobolographic analysis revealed no motor deficits." | 1.28 | Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat. ( Gebhart, GF; Maves, TJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dewinter, G | 1 |
| Coppens, S | 1 |
| Van de Velde, M | 1 |
| D'Hoore, A | 1 |
| Wolthuis, A | 1 |
| Cuypers, E | 1 |
| Rex, S | 1 |
| Cooke, C | 1 |
| Kennedy, ED | 1 |
| Foo, I | 1 |
| Nimmo, S | 1 |
| Speake, D | 1 |
| Paterson, HM | 1 |
| Ventham, NT | 1 |
| Staikou, C | 1 |
| Avramidou, A | 1 |
| Ayiomamitis, GD | 1 |
| Vrakas, S | 1 |
| Argyra, E | 1 |
| Stuhldreher, JM | 1 |
| Adamina, M | 1 |
| Konopacka, A | 1 |
| Brady, K | 1 |
| Delaney, CP | 1 |
| Adanır, T | 1 |
| Aksun, M | 1 |
| Yılmaz Karaören, G | 1 |
| Karabuğa, T | 1 |
| Nazlı, O | 1 |
| Sencan, A | 1 |
| Köseoğlu, M | 1 |
| Herroeder, S | 1 |
| Pecher, S | 1 |
| Schönherr, ME | 1 |
| Kaulitz, G | 1 |
| Hahnenkamp, K | 1 |
| Friess, H | 1 |
| Böttiger, BW | 1 |
| Bauer, H | 1 |
| Dijkgraaf, MG | 1 |
| Dijkgraaf, OG | 1 |
| Durieux, ME | 1 |
| Hollmann, MW | 1 |
| Maves, TJ | 1 |
| Gebhart, GF | 1 |
| Joseph, AA | 1 |
| Kincl, FA | 1 |
| D'Addabbo, A | 1 |
| Dammacco, F | 1 |
| Capurso, A | 1 |
| Damato, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Prospective Study Comparison of Erector Spinae Plane Block and Intrathecal Opioid for Postoperative Analgesia After Laparoscopic Colorectal Surgery in an Enhanced Recovery Setting[NCT05257941] | Phase 1/Phase 2 | 126 participants (Anticipated) | Interventional | 2022-01-27 | Recruiting | ||
| Therapeutic Efficacy of Intravenous Lidocaine Infusion Compared With Epidural Analgesia for Postoperative Pain Control in Adult Patients Undergoing Major Abdominal Surgery: Non-Inferiority Clinical Trial[NCT04017013] | Phase 4 | 210 participants (Actual) | Interventional | 2020-03-01 | Completed | ||
| The Effect of Intravenous Infusions of Lidocaine and Magnesium Versus Lidocaine and Ketamine Versus Lidocaine Alone on Recovery Profile and Postoperative Pain After Elective Gynecological Surgery[NCT04622904] | 90 participants (Anticipated) | Interventional | 2020-11-14 | Recruiting | |||
| Intravenous Lidocaine for Perioperative and Postoperative Analgesia[NCT03921567] | Phase 4 | 520 participants (Anticipated) | Interventional | 2019-04-15 | Recruiting | ||
| Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies[NCT02623803] | Phase 4 | 48 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| Intravenous Lidocaine for Postoperative Recovery in Liver Surgery, a Randomized Double Blinded Placebo-controlled Study[NCT05153785] | Phase 2/Phase 3 | 80 participants (Anticipated) | Interventional | 2021-11-15 | Recruiting | ||
| Comparing Analgesic Efficacy of Systemic Lidocaine Against Placebo in General Anesthesia in Bariatric Surgery: Prospective, Randomized, Double-blinded, Placebo Controlled, Mono-Center Study[NCT03667001] | Phase 3 | 140 participants (Actual) | Interventional | 2018-11-16 | Completed | ||
| IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery: Effects on Postoperative Recovery and Cancer Recurrence[NCT01204242] | Phase 2 | 78 participants (Actual) | Interventional | 2009-08-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Time of first instance of a bowel movement will be measured as the number of days post operatively for bowel function to return. (NCT02623803)
Timeframe: up to 3 weeks postoperatively
| Intervention | days (Mean) |
|---|---|
| Treatment Group | 5.8 |
| Control Group | 5.2 |
Time of first instance of flatus will be measured as the number of days post operatively for bowel function to return. (NCT02623803)
Timeframe: up to 3 weeks postoperatively
| Intervention | days (Mean) |
|---|---|
| Treatment Group | 3.9 |
| Control Group | 2.7 |
Total opioid consumption in PACU converted to morphine equivalents in mg. (NCT02623803)
Timeframe: up to 4 hours post-operatively
| Intervention | mg (Mean) |
|---|---|
| Treatment Group | 3.9 |
| Control Group | 6.7 |
Overall pain will be measured 30 minutes after arrival at the post-operative care unit (PACU) using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: 30 minutes after arrival to PACU
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 3.3 |
| Control Group | 5.3 |
Overall pain will be measured approximately 12 hours post-operatively using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: approximately 12 hours post-operatively
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 4.4 |
| Control Group | 5.4 |
Overall pain will be measured on post-operative day 1 at 1 pm using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: post-operative day 1 at 1 pm
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 4.8 |
| Control Group | 4.8 |
Overall pain will be measured on post-operative day 1 at 1am using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: post-operative day 1 at 1am
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 5.1 |
| Control Group | 5.5 |
Overall pain will be measured upon arrival at the post-operative care unit (PACU) using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: baseline - arrival at the PACU
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 1.6 |
| Control Group | 2.7 |
Pain at rest will be measured 30 minutes after arrival at the post-operative care unit (PACU) using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: 30 minutes after arrival to PACU
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 3.3 |
| Control Group | 5.1 |
Pain at rest will be measured approximately 12 hours post-operatively using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: approximately 12 hours post-operatively
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 4.0 |
| Control Group | 5.0 |
Pain at rest will be measured at post-operative day 1 at 1 pm using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: post-operative day 1 at 1 pm
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 4.0 |
| Control Group | 4.8 |
Pain at rest will be measured on post-operative day 1 at 1 am using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: post-operative day 1 at 1 am
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 4.0 |
| Control Group | 4.6 |
Pain will be measured at rest upon arrival at the post-operative care unit (PACU) using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: baseline - arrival at the PACU
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 2.1 |
| Control Group | 2.6 |
Pain with coughing will be measured 30 minutes after arrival at the post-operative care unit (PACU) using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: 30 minutes after arrival to PACU
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 4.3 |
| Control Group | 5.8 |
Pain with coughing will be measured approximately 12 hours post-operatively using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: approximately 12 hours post-operatively
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 4.7 |
| Control Group | 7.6 |
Pain with coughing will be measured on post-operative day 1 at 1 am using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: post-operative day 1 at 1 am
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 5.4 |
| Control Group | 7.1 |
Pain with coughing will be measured on post-operative day 1 at 1 pm using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: post-operative day 1 at 1 pm
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 5.4 |
| Control Group | 5.8 |
Pain with coughing will be measured upon arrival at the post-operative care unit (PACU) using numerical rating scale (NSR). Subjects will rate their pain after surgery on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. (NCT02623803)
Timeframe: baseline - arrival at the PACU
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Group | 2.3 |
| Control Group | 2.5 |
Total amount of opioids converted to morphine equivalents in mg administered in the first 24 hours after surgery. (NCT02623803)
Timeframe: up to 24 hours post-operatively
| Intervention | mg (Mean) |
|---|---|
| Treatment Group | 7.4 |
| Control Group | 7.9 |
This questionnaire is a short 15 question form that measures the quality of a subject's postoperative recovery. The scale is ranked from 0 to 10, where 0 is a poor response and 10 is an excellent response. (NCT02623803)
Timeframe: Day 15 post-operatively
| Intervention | score on a scale (Mean) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Able to breathe easily | Been able to enjoy food | Feeling rested | Have had a good sleep | Able to look after personal toliet and hygiene | Able to communicate with family or friends | Getting support from hospital doctors and nurse | Able to return to work or usual home activities | Feeling comfortable and in control | Having a feeling of general well-being | Moderate pain | Severe pain | Nausea or vomiting | Feeling worried or anxious | Feeling sad or depressed | |
| Control Group | 8.7 | 5.4 | 6.0 | 6.6 | 8.8 | 9.3 | 9.5 | 4.9 | 6.7 | 6.7 | 6.6 | 8.8 | 8.2 | 7.6 | 7.8 |
| Treatment Group | 9.1 | 6.2 | 7.2 | 7.1 | 9.2 | 9.6 | 8.8 | 5.4 | 7.1 | 7.5 | 7.9 | 9.4 | 8.6 | 7.7 | 8.4 |
1 review available for lidocaine and Colonic Diseases
| Article | Year |
|---|---|
Meta-analysis of the effect of perioperative intravenous lidocaine on return of gastrointestinal function after colorectal surgery.
Topics: Administration, Intravenous; Adolescent; Adult; Analgesics, Opioid; Anesthetics, Local; Colonic Dise | 2019 |
3 trials available for lidocaine and Colonic Diseases
| Article | Year |
|---|---|
Quadratus Lumborum Block Versus Perioperative Intravenous Lidocaine for Postoperative Pain Control in Patients Undergoing Laparoscopic Colorectal Surgery: A Prospective, Randomized, Double-blind Controlled Clinical Trial.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Local; Belgium; Colonic Diseas | 2018 |
Effects of intravenous versus epidural lidocaine infusion on pain intensity and bowel function after major large bowel surgery: a double-blind randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Colonic Diseases; Defecation; Digestive System S | 2014 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Biomarkers; CD11b Antigen; Colectomy; Colonic Diseases; | 2007 |
5 other studies available for lidocaine and Colonic Diseases
| Article | Year |
|---|---|
Effect of local anesthetics on postoperative pain and opioid consumption in laparoscopic colorectal surgery.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Analysis of Variance; | 2012 |
Effect of epidural anesthesia on anastomotic leakage in colonic surgery: experimental study.
Topics: Anastomosis, Surgical; Anastomotic Leak; Anesthesia, Epidural; Anesthetics, Local; Animals; Colonic | 2012 |
Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat.
Topics: Analgesia, Epidural; Animals; Blood Pressure; Cerebrospinal Fluid; Colonic Diseases; Dose-Response R | 1992 |
Toxic and antifertility effects of quinacrine hydrochloride in rats.
Topics: Animals; Atrophy; Autopsy; Colonic Diseases; Dose-Response Relationship, Drug; Drug Synergism; Embry | 1974 |
[Clinical and animal experiment studies of the resorption of dyes and colloidal radiogold in the large intestine].
Topics: Animals; Azo Compounds; Colitis, Ulcerative; Colon; Colonic Diseases; Enema; Gold Colloid, Radioacti | 1969 |